
|Articles|February 1, 2002
Botulinum shows promise for added urologic indications
Jena, Germany-Botulinum toxin has shown promise as a potential therapy for chronic pelvic pain and lower urinary tract dysfunction. In a German study, injection of botulinum toxin type A into the urethral sphincter muscle led to improvement in muscle tone, pain, and urodynamic parameters in patients enrolled.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Initial prostate cancer presentation, family history linked to survival in mCRPC
2
State of Men’s Health Act: What urologists need to know
3
Nicole L. Miller, MD, FACS, on persistent LUTS after BPH treatment
4
Datopotamab deruxtecan enters phase 3 trial in high-risk muscle-invasive urothelial cancer
5












